Strategic Research Agenda
Strategic Research Agenda
“It’s a worldwide concern that antibiotics, which have allowed us to treat previously deadly bacterial infections and save many lives, are now becoming less and less effective. It’s therefore crucial to immediately join forces under one research agenda to achieve a greater global impact,” says Herman Goossens from the Scientific Advisory Board. Within this context, JPIAMR has developed a strategic research agenda (SRA), which is supported by the initiative’s member states and other international players. The Strategic Research Agenda aims to:
- To bring together all players in the field for a multi-dimensional approach
- To provide a platform for partners to collaborate in a tailor-made fashion on specific topics
- To harmonise joint actions and create greater impact
- To reduce research overlaps
- To create awareness and knowledge
- To stand a chance of actually finding a solution to the AMR problem
Actions within six priority topics will be translated into new prevention and intervention strategies to improve public health and deliver economic and societal benefits throughout Europe and beyond.
- Therapeutics: The improvement of current antibiotics and the development of new antibiotics and alternatives for antibiotics.
- Diagnostics: New and improved diagnostics to stimulate better use of current antibiotics and support the development and use of new antibiotics and alternatives to antibiotics.
- Surveillance: An international, standardised surveillance programme for AMR and antibiotic use in human, and agricultural settings.
- Transmission: A comprehensive, multi-disciplinary understanding of the transmission mechanisms.
- Environment: The assessment of the contribution of pollution of the environment and the development of strategies to minimize environmental contamination.
- Interventions: The study of preventative and control interventions.
To tackle antibiotic resistance, the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), through its strategic research agenda, will pull together international efforts to achieve sustainable future use of antibiotics. This multi-dimensional effort will provide new prevention and intervention strategies to improve public health and wellbeing of populations and deliver economic and societal benefits. More concretely, JPIAMR, through its SRA will anchor the priority topics through:
- Establishing a biobank of clinical specimens and strains
- Establishing a database containing information on on-going AMR research (including veterinary and environmental samples)
- Collaborating with stakeholders
- Raising awareness of AMR
Putting focus on antibiotic resistance in bacteria that cause life-threatening infection during hospitalisation